U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241975) titled 'Real-world Experience With the Available Outpatient COVID-19 Therapies in Patients With Cancer: an Ambispective Cohort Study' on Nov. 17.
Brief Summary: The real-life efficacy of early antiviral therapies in cancer patients with COVID-19 is largely uncharacterized. From these unresolved issues, it is therefore necessary to fill these knowledge gaps by assessing the efficacy and safety of these therapies in combination with anti-cancer therapies.
Study Start Date: Aug. 23, 2022
Study Type: OBSERVATIONAL
Condition:
Cancer Patients in Treatment Active Who Receive Early Out-patient Therapy Against SARS-CoV-2
Recruitment Status: COM...